The product information for Gardasil® has been updated to include the clinical efficacy and safety of the vaccine for women up to 45 years of age. - The product information of the four-type (6,11,16,18) human papillomavirus (HPV) vaccine Gardasil® has been updated to include the … [Read more...] about MERCK Press Release Touting Clinical Efficacy of Gardasil for Mature Women
FDA experts back Merck's application to extend the use of Gardasil to males In twin votes likely to add considerable force to U.S. marketing efforts for HPV vaccines, an FDA expert panel has voted to back GlaxoSmithKline's long delayed application to market its HPV vaccine … [Read more...] about Cervarix On Track for FDA Approval, Garasil to Have Expanded Use
Fresh controversies are heating up over the marketing of products to prevent cervical cancer The U.S. Food & Drug Administration is gearing up to make critical decisions about two controversial vaccines. On Sept. 9 an FDA advisory committee will consider whether Merck … [Read more...] about Is Merck Overselling a Cancer Vaccine?
...Push Gardasil to achieve greater vaccination rates Less then a month after a JAMA article critized Merck for aggressively marking Gardasil, Merck is planning a big-time advertising push on Gardasil, hoping to revive flagging sales of the human papillomavirus vaccine. As … [Read more...] about Merck’s Back-to-School Special…
This week has shown that a large number of reports stating that Gardasil is proving unsafe. News stations around the world have reported that Gardasil the HPV vaccine has been found to cause adverse reactions. The adverse reactions range from mild, such as headaches, nausea and … [Read more...] about Gardasil is proven dangerous, yet it is still mandatory for immigrants